Prostate Pain
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy (NCT04288427) | Beth Israel Deaconess Medical Center | 2020-09-25 |
Track Prostate Pain automatically
Every clearance here is in the API, with alerts when new ones post.